Highlights
- 12 weeks of PEMF therapy significantly reduced systolic and diastolic blood pressure
- Improvement in endothelial function assessed by flow-mediated dilation (FMD)
- Portable, low-intensity PEMF device used in a home-based protocol
- No significant changes in nitric oxide levels observed
- Non-invasive intervention evaluated in hypertensive adults
Study Design
This study investigated the effects of pulsed electromagnetic field (PEMF) therapy on vascular function and blood pressure in individuals with hypertension.
Thirty participants with elevated blood pressure (SBP > 130 mmHg and/or MAP > 100 mmHg) were allocated to either a PEMF intervention group (n = 15) or a control group (n = 15).
The PEMF group used a small, portable device delivering low-intensity magnetic fields (approximately 0.20 mT) at a frequency of 30 Hz. Participants applied PEMF therapy three times per day for 12 weeks.
Primary assessments included flow-mediated dilation (FMD), blood pressure (SBP, DBP, MAP), and circulating nitric oxide levels, measured before and after the intervention period.
What Did They Find?
After 12 weeks, participants in the PEMF group demonstrated:
- Significant improvements in endothelial function, reflected by increased FMD and normalized FMD
- Reductions in systolic, diastolic, and mean arterial pressure
No significant changes were observed in the control group. Nitric oxide levels remained unchanged in both groups throughout the study period.
Figure 1. Changes in Vascular Function and Blood Pressure After 12 Weeks of PEMF Therapy. Absolute changes from baseline to 12 weeks, comparing the pulsed electromagnetic field (PEMF) group and the control group. Positive values indicate improved endothelial function (FMD), while negative values indicate reductions in blood pressure (SBP, DBP, and MAP).
PEMF = pulsed electromagnetic field; FMD = flow-mediated dilation; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure.
Why It Matters
Endothelial dysfunction and elevated blood pressure are key contributors to cardiovascular risk in hypertensive individuals. Improving vascular function is a critical target for non-pharmacological interventions.
This study suggests that regular exposure to low-intensity PEMF therapy may positively influence vascular health and blood pressure control through mechanisms independent of systemic nitric oxide changes. PEMF therapy may represent a promising, non-invasive adjunct strategy for cardiovascular health, although further research is needed to clarify its underlying biological mechanisms.
Reference: Stewart GM, Wheatley-Guy CM, Johnson BD, Shen WK, Kim CH. Impact of pulsed electromagnetic field therapy on vascular function and blood pressure in hypertensive individuals. J Clin Hypertens (Greenwich). 2020;22(6):1083-1089. doi:10.1111/jch.13877